Education
About Us
Working with TipRanks
Follow Us
Zymeworks Inc (ZYME)
NASDAQ:ZYME
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 105.97M | $ 76.30M | $ 76.01M | $ 412.48M | $ 26.68M |
| Gross Profit | $ 95.17M | $ 76.30M | $ -66.98M | $ 412.48M | $ 26.68M |
| Operating Income | $ -92.55M | $ -137.11M | $ -138.05M | $ 130.53M | $ -215.63M |
| EBITDA | $ 7.65B | $ -108.62M | $ -120.70M | $ 142.49M | $ -206.09M |
| Net Income | $ -81.13M | $ -122.69M | $ -118.67M | $ 124.34M | $ -211.84M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 228.80M | $ 225.78M | $ 374.33M | $ 492.23M | $ 252.61M |
| Total Assets | $ 346.53M | $ 463.09M | $ 580.88M | $ 648.73M | $ 389.13M |
| Total Debt | $ 18.27M | $ 18.51M | $ 26.72M | $ 28.11M | $ 32.33M |
| Net Debt | $ -22.89M | $ -47.60M | $ -130.84M | $ -372.80M | $ -169.53M |
| Total Liabilities | $ 78.03M | $ 124.32M | $ 116.07M | $ 155.77M | $ 140.04M |
| Stockholders' Equity | $ 268.50M | $ 338.77M | $ 464.81M | $ 492.96M | $ 249.09M |
| Cash Flow | |||||
| Free Cash Flow | $ -34.53M | $ -113.11M | $ -122.38M | $ 130.98M | $ -205.74M |
| Operating Cash Flow | $ -33.01M | $ -110.04M | $ -118.30M | $ 144.11M | $ -192.45M |
| Investing Cash Flow | $ 26.66M | $ 38.76M | $ -207.25M | $ -53.85M | $ 144.60M |
| Financing Cash Flow | $ -18.56M | $ -20.45M | $ 81.85M | $ 108.58M | $ 8.01M |